1. Home
  2. PLMR vs AMRX Comparison

PLMR vs AMRX Comparison

Compare PLMR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palomar Holdings Inc.

PLMR

Palomar Holdings Inc.

HOLD

Current Price

$114.86

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.25

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLMR
AMRX
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
PLMR
AMRX
Price
$114.86
$12.25
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$153.60
$15.60
AVG Volume (30 Days)
245.1K
1.4M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
60.04
157.89
EPS
1.57
0.19
Revenue
$875,967,000.00
N/A
Revenue This Year
$192.25
$4.48
Revenue Next Year
$19.34
$7.13
P/E Ratio
$72.46
$62.03
Revenue Growth
58.16
N/A
52 Week Low
$107.51
$7.02
52 Week High
$175.85
$15.42

Technical Indicators

Market Signals
Indicator
PLMR
AMRX
Relative Strength Index (RSI) 45.95 43.28
Support Level $109.89 $11.60
Resistance Level $136.20 $12.85
Average True Range (ATR) 4.75 0.41
MACD 0.18 -0.12
Stochastic Oscillator 47.67 23.32

Price Performance

Historical Comparison
PLMR
AMRX

About PLMR Palomar Holdings Inc.

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: